Education
About Us
Working with TipRanks
Follow Us
Design Therapeutics (DSGN)
NASDAQ:DSGN
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 226.00 |
| Gross Profit | $ 0.00 | $ -537.00K | $ -466.00K | $ -129.00K | $ -4.77K |
| Operating Income | $ -62.38M | $ -78.19M | $ -67.59M | $ -35.83M | $ -8.33M |
| EBITDA | $ -62.38M | $ -66.33M | $ -62.84M | $ -35.70M | $ -8.32M |
| Net Income | $ -49.59M | $ -66.86M | $ -58.62M | $ -35.53M | $ -8.28M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 245.48M | $ 281.80M | $ 330.39M | $ 384.06M | $ 36.09M |
| Total Assets | $ 252.09M | $ 289.64M | $ 341.14M | $ 390.56M | $ 36.52M |
| Total Debt | $ 1.53M | $ 3.05M | $ 3.69M | $ 3.63M | $ 0.00 |
| Net Debt | $ -21.03M | $ -18.15M | $ -22.81M | $ -294.94M | $ -2.38M |
| Total Liabilities | $ 10.00M | $ 11.96M | $ 13.83M | $ 8.43M | $ 47.83M |
| Stockholders' Equity | $ 242.10M | $ 277.69M | $ 327.31M | $ 382.13M | $ -11.31M |
| Cash Flow | |||||
| Free Cash Flow | $ -43.45M | $ -58.82M | $ -52.23M | $ -30.91M | $ -8.74M |
| Operating Cash Flow | $ -43.10M | $ -58.56M | $ -51.32M | $ -29.38M | $ -8.67M |
| Investing Cash Flow | $ 43.95M | $ 52.54M | $ -220.99M | $ -53.64M | $ -33.56M |
| Financing Cash Flow | $ 513.00K | $ 724.00K | $ 235.00 | $ 379.21K | $ 44.53M |